Drug Screening Using Novel IMD in Salivary and Head and Neck Cancers
EARLY_PHASE1
30
about 8.3 years
18+
2 sites in MA
What this study is about
This trial is testing a new device, called an implantable microdevice (IMD), as a possible treatment for salivary gland cancers and head and neck cancers. The goal of this early-phase trial is to evaluate the safety and effectiveness of the IMD in adults.
Simplified from trial records by PatientMatch.
What you may be asked to do
- 1.Use Implantable Microdevice (IMD)
Participation Burden
What's physically and logistically required of participants.
Requires travel to a study site
How treatment is administered
Everyone gets the investigational treatment.
Extracted study details
Pulled from the trial record to show what is being tested and what the study is measuring.
Primary: Grade 3 or Higher Treatment-Related Toxicity Rate
Secondary: Biomarker levels, Gene Expression Level, Pharmacodynamic (PD), Tumor Response
Oncology